Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS von Luger, S M, Ringdén, O, Zhang, M-J, Pérez, W S, Bishop, M R, Bornhauser, M, Bredeson, C N, Cairo, M S, Copelan, E A, Gale, R P, Giralt, S A, Gulbas, Z, Gupta, V, Hale, G A, Lazarus, H M, Lewis, V A, Lill, M C, McCarthy, P L, Weisdorf, D J, Pulsipher, M A

Volltext

Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enr... von Ganzel, C., Wang, Y., Roopcharan, K., Sun, Z., Rowe, J. M., Fernandez, H. F., Paietta, E. M., Luger, S. M., Lazarus, H. M., Cripe, L. D., Douer, D., Wiernik, P. H., Tallman, M. S., Litzow, M. R.

Volltext

Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 c... von Ganzel, C., Wang, Y., Roopcharan, K., Sun, Z., Rowe, J. M., Fernandez, H. F., Paietta, E. M., Luger, S. M., Lazarus, H. M., Cripe, L. D., Douer, D., Wiernik, P. H., Tallman, M. S., Litzow, M. R.

Volltext

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma von Olin, R L, Vogl, D T, Porter, D L, Luger, S M, Schuster, S J, Tsai, D E, Siegel, D L, Cook, R J, Mangan, P A, Cunningham, K, Stadtmauer, E A

Volltext

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells von JORDAN, C. T, UPCHURCH, D, LUGER, S. M, PHILLIPS, G. L, SZILVASSY, S. J, GUZMAN, M. L, HOWARD, D. S, PETTIGREW, A. L, MEYERROSE, T, ROSSI, R, GRIMES, B, RIZZIERI, D. A

Volltext

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT von Tizon, R, Frey, N, Heitjan, D F, Tan, K S, Goldstein, S C, Hexner, E O, Loren, A, Luger, S M, Reshef, R, Tsai, D, Vogl, D, Davis, J, Vozniak, M, Fuchs, B, Stadtmauer, E A, Porter, D L

Volltext

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD von Rager, A, Frey, N, Goldstein, S C, Reshef, R, Hexner, E O, Loren, A, Luger, S M, Perl, A, Tsai, D, Davis, J, Vozniak, M, Smith, J, Stadtmauer, E A, Porter, D L

Volltext

Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen von Nazha, A, Cook, R, Vogl, D T, Mangan, P A, Gardler, M, Hummel, K, Cunningham, K, Luger, S M, Porter, D L, Schuster, S, O'Doherty, U, Siegel, D, Stadtmauer, E A

Volltext

Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation von SVOBODA, J, ANDREADIS, C, LOREN, A. W, SIEGEL, D. L, GLATSTEIN, E, ALAVI, A, STADTMAUER, E. A, SCHUSTER, S. J, ELSTROM, R, CHONG, E. A, DOWNS, L. H, BERKOWITZ, A, LUGER, S. M, PORTER, D. L, NASTA, S, TSAI, D

Volltext

High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL von Tasian, S K, Hurtz, C, Wertheim, G B, Bailey, N G, Lim, M S, Harvey, R C, Chen, I-M, Willman, C L, Astles, R, Zebrowski, A, Reshmi, S C, Li, M M, Frey, N V, Luger, S M, Carroll, M, Perl, A E

Volltext

Effect of postremission chemotherapy before human leukocyte antigen–identical sibling transplantation for acute myelogenous leukemia in first complete remission von Tallman, Martin S., Rowlings, Philip A., Milone, Gustavo, Zhang, Mei-Jie, Perez, Waleska S., Weisdorf, Daniel, Keating, Armand, Gale, Robert Peter, Geller, Robert B., Laughlin, Mary J., Lazarus, Hillard M., Luger, Selina M., McCarthy, Philip L., Rowe, Jacob M., Saez, Ruben A., Vowels, Marcus R., Horowitz, Mary M.

Volltext

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease von COHEN, A. D, LUGER, S. M, SICKLES, C, MANGAN, P. A, PORTER, D. L, SCHUSTER, S. J, TSAI, D. E, NASTA, S, GEWIRTZ, A. M, STADTMAUER, E. A

Volltext

Allogeneic transplant for FLT3-ITD+ AML: room for improvement von Perl, A E, Luger, S M

Volltext

The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults von Litzow, M R, Fielding, A K, Luger, S M, Paietta, E, Ofran, Y, Rowe, J M, Goldstone, A H, Tallman, M S, Lazarus, H M

Volltext

Autologous stem cell transplant in ALL: who should we be transplanting in first remission? von MATO, A. R, LUGER, S. M

Volltext

In vivo Treatment of Human Leukemia in a Scid Mouse Model with c-myb Antisense Oligodeoxynucleotides von Ratajczak, Mariusz Z., Kant, Jeffrey A., Luger, Selina M., Hijiya, Nobuko, Zhang, Jin, Zon, Gerald, Gewirtz, Alan M.

Volltext

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma von ANDREADIS, C, SCHUSTER, S. J, DOWNS, L. H, MANGAN, P. A, CUNNINGHAM, K. A, HUMMEL, K. A, GIMOTTY, P. A, SIEGEL, D. L, GLATSTEIN, E, STADTMAUER, E. A, CHONG, E. A, SVOBODA, J, LUGER, S. M, PORTER, D. L, TSAI, D. E, NASTA, S. D, ELSTROM, R. L, GOLDSTEIN, S. C

Volltext

Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy von BUCKANOVICH, R. J, LIU, G, STRICKER, C, LUGER, S. M, STADTMAUER, E. A, SCHUSTER, S. J, DUFFY, K, TSAI, D, PRUITT, A, PORTER, D. L

Volltext

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation von LOREN, A. W, LUGER, S. M, GREEN, J, EMERSON, S. G, PORTER, D. L, STADTMAUER, E. A, TSAI, D. E, SCHUSTER, S, NASTA, S. D, GOLDSTEIN, S. C, PERL, A, ORLOFF, G, OLIVER, J. C

Volltext

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide von Westervelt, Peter, Brown, Randy A., Adkins, Douglas R., Khoury, Hanna, Curtin, Peter, Hurd, David, Luger, Selina M., Ma, Margaret K., Ley, Timothy J., DiPersio, John F.

Volltext